Thyrocare Technologies Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Thyrocare Technologies Ltd. on BSE

Load latest

Thyrocare Technologies Ltd.

16 Sep 2022

1001.30

0.12%

Company Update

Thyrocare Technologies Ltd - 539871 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

BSE India

we wish to inform you that our MD & CEO, Mr. Rahul Guha would be meeting, on invitation of Goldman Sachs (India) Alternative Investment Management Private Limited.

pdf

Thyrocare Technologies Ltd.

16 Sep 2022

1001.30

0.12%

SAST

Thyrocare Technologies Ltd - 539871 - Disclosures of reasons for encumbrance by promoter of listed companies …

BSE India

The Exchange has received the Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011 on September 15, 2022 for Docon Technologies Pvt Ltd & API Holdings Ltd

pdf

Thyrocare Technologies Ltd.

16 Sep 2022

1001.30

0.12%

SAST

Thyrocare Technologies Ltd - 539871 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, …

BSE India

The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on September 15, 2022 for Docon Technologies Pvt Ltd & API Holdings Ltd

pdf

Thyrocare Technologies Ltd.

16 Sep 2022

1001.30

0.12%

SAST

Thyrocare Technologies Ltd - 539871 - Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011

BSE India

The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Vistra ITCL (India) Ltd

pdf

Thyrocare Technologies Ltd.

14 Sep 2022

1001.30

0.12%

Company Update

Thyrocare Technologies Ltd - 539871 - Schedule Of Analysts/Institutional Investor Meet/Con. Call

BSE India

our MD & CEO, Mr. Rahul Guha and CFO, Mr. Sachin Salvi, would be attending, on invitation, the following on-going Investor conferences arranged by the following, to be held through Virtual Conferencing: 1) Incred Research Services. 2) Alder Capital 3) Tamohara Investment 4) Mirabilis Investment Trust 5) Nippon Asset Management.

pdf

Thyrocare Technologies Ltd.

09 Sep 2022

1001.30

0.12%

Company Update

Thyrocare Technologies Ltd - 539871 - Clarification Sought By BSE On "Spurt In Volume Of Shares …

BSE India

With reference to your letter No. L/SURV/ONL/PV/RS/ 2022-2023 / 187 dated September 09, 2022 sent to us by mail, we wish to reply as follows: 1. We have been disclosing all the information / particulars as per the provisions of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015. 2. There are no price sensitive information /announcement (including any impending announcement), which in our opinion may have a bearing on the price/volume behaviour in the scrip, and which have not been disclosed. 3. You will agree that such spurt or dip in the volume has become a regular feature not only in our script but also in the scrips of other listed peers.

pdf

Thyrocare Technologies Ltd.

09 Sep 2022

1001.30

0.12%

Company Update

Thyrocare Technologies Ltd - 539871 - Clarification sought from Thyrocare Technologies Ltd

BSE India

The Exchange has sought clarification from Thyrocare Technologies Ltd on September 9, 2022, with reference to Movement in Volume.The reply is awaited.

Thyrocare Technologies Ltd.

05 Aug 2022

1001.30

0.12%

Earnings Call

Thyrocare Technologies Ltd - 539871 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

BSE India

Transcript of Earnings Call held on 02-08-2022 for Analysts / Investors

pdf

Thyrocare Technologies Ltd.

05 Aug 2022

1001.30

0.12%

AGM

Thyrocare Technologies Ltd - 539871 - Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)

BSE India

Thyrocare Technologies Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here